Author Archive

Three F.D.A. Advisers Resign Over Approval of Alzheimer’s Drug – The New York Times

  1. Three F.D.A. Advisers Resign Over Approval of Alzheimer’s Drug  The New York Times
  2. Controversial New Alzheimer’s Drug: What to Know  WebMD
  3. New Alzheimer’s drug won’t ‘bring Mom back to two years ago,’ doctor says  NBC News
  4. New Alzheimer’s drug aducanumab: cost, side effects, timeline and other questions answered  CNN
  5. FDA’s Approval of Alzheimer’s Drug Leads to Third Adviser’s Resignation  The Wall Street Journal
  6. View Full Coverage on Google News

Go to News Source


New Alzheimer’s drug aducanumab: cost, side effects, timeline and other questions answered – CNN

  1. New Alzheimer’s drug aducanumab: cost, side effects, timeline and other questions answered  CNN
  2. New Alzheimer’s drug won’t ‘bring Mom back to two years ago,’ doctor says  NBC News
  3. Biogen’s new Alzheimer’s drug could cost Medicare billions after FDA approval  Vox.com
  4. Medicare copays for new Alzheimer’s drug could reach $11,500  ABC News
  5. Two FDA Panel Members Resign Over Alzheimer’s Drug Approval  Medscape
  6. View Full Coverage on Google News

Go to News Source